NORTH SOUTH VC, LLC

Thesis

North South Ventures (NSV), founded in 2021 and headquartered in San Francisco, is a venture capital firm specializing in early-stage investments within the healthcare sector, including biotechnology, medical devices, and digital health/AI. They strategically leverage locations near major academic medical centers like Stanford/UCSF and the University of Toronto to identify promising startups. NSV's investment thesis centers on pre-seed and seed-stage companies, aiming to invest before later-stage valuations increase. Their strategy involves sizing investments to meet company needs and reserving capital for follow-on rounds. NSV employs a unique 'hybrid approach to venture capital,' blending a fund-of-funds strategy with direct investments in early-stage companies to offer balanced access to the VC asset class while retaining upside potential. Key focus sectors include therapeutics, platforms and tools, diagnostics, devices, health IT/digital, and science-anchored consumer products. Geographically, they primarily focus on the United States, with strong ties to North American research hubs and an openness to global founders, also maintaining a presence in Canada. While specific AUM is not publicly disclosed, one source indicates total funds raised exceeding $4 billion, with a typical investment size of $6 million.

Related lists

• Pre-seed investors based in San Francisco, CA
• Seed investors based in San Francisco, CA